Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Progenics' Azedra becomes first FDA-approved treatment for adrenal tumours

pharmafileAugust 02, 2018

Tag: FDA , adrenal tumours

PharmaSources Customer Service